• Info
  • Insider Ownership

Insider Trading & Ownership of Melissa B. Epperly

Location
New York, NY
Summary
The estimated net worth of Melissa B. Epperly is at least $6,489,718 dollars as of 22 Jan 2026. Melissa B. Epperly is the Chief Financial Officer of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $5.16M. Melissa B. Epperly is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $1.33M.
Signature
By: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly
All Insider Reports
All Insider Reports

Notify me when Melissa B. Epperly files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Melissa B. Epperly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ZNTL Zentalis Pharmaceuticals, Inc. Chief Financial Officer $5,164,577 12 Feb 2024
ROIV Roivant Sciences Ltd. Director $1,325,141 20 Jan 2026
KNTE Kinnate Biopharma Inc. Director 03 Apr 2024
NAUT Nautilus Biotechnology, Inc. Director 23 Jun 2025

Insider Transactions Reported by Melissa B. Epperly:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.